|
Tabla 2: Principales características del tratamiento. |
||||
|
Característica |
Total N = 96 n (%) |
≤ 5 meses N = 39 n (%) |
> 5 meses N = 57 n (%) |
p |
|
Quimioterapia neoadyuvante |
NS |
|||
|
Sí |
67 (69.8) |
21 (53.8) |
46 (80.7) |
|
|
No |
29 (30.2) |
18 (46.2) |
11 (19.3) |
|
|
Necrosis tumoral (Huvos) |
NS |
|||
|
No aplica |
42 (43.8) |
12 (30.8) |
30 (52.6) |
|
|
GI |
21 (21.9) |
6 (15.4) |
15 (26.3) |
|
|
GII |
25 (26.0) |
14 (35.9) |
11 (19.3) |
|
|
GIII |
7 (7.3) |
6 (15.4) |
1 (1.8) |
|
|
GIV |
1 (1.0) |
1 (2.6) |
0 (0.0) |
|
|
Cirugía preservadora |
0.001 |
|||
|
Sí |
45 (46.9) |
27 (69.2) |
18 (31.6) |
|
|
No |
51 (53.1) |
12 (30.8) |
39 (68.4) |
|
|
Tipo de cirugía |
NS |
|||
|
No aplica |
22 (22.9) |
2 (5.1) |
20 (35.1) |
|
|
Resección amplia + artroplastía |
27 (28.1) |
18 (46.2) |
9 (15.8) |
|
|
Resección amplia |
18 (18.8) |
10 (25.6) |
7 (12.3) |
|
|
Amputación |
20 (20.8) |
6 (15.4) |
14 (24.6) |
|
|
Desarticulación |
8 (8.3) |
3 (7.7) |
6 (10.5) |
|
|
Hemipelvectomía externa |
1 (1.0) |
0 (0.0) |
1 (1.8) |
|